Related Experiment Video
Updated: Mar 12, 2026
11:24
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
Published on: February 10, 2018
14.8K
Hepatocyte Transplantation in Children
Louise Coppin1, Etienne Sokal2, Xavier Stephenne3
1Service de Gastroentérologie et Hépatologie Pédiatrique, Cliniques Universitaires Saint Luc, Université catholique de Louvain, Avenue Hippocrate 10, 1200, Bruxelles, Belgium. coppinlouise@gmail.com.
Methods in Molecular Biology (Clifton, N.J.)
|November 11, 2016
Summary
Hepatocyte transplantation offers a promising alternative to liver transplantation for metabolic disorders. This approach bypasses organ donor limitations and surgical risks associated with traditional liver replacement therapies.
Area of Science:
- Hepatology and Regenerative Medicine
- Metabolic Disease Research
- Transplantation Science
Background:
- The liver is vital for metabolism, and liver failure necessitates transplantation.
- Orthotopic liver transplantation (OLT) is a standard treatment but faces challenges like organ scarcity and surgical risks.
- Alternative therapies are needed for liver-based metabolic disorders.
Purpose of the Study:
- To explore hepatocyte transplantation as a viable alternative to OLT.
- To evaluate the potential of cell-based therapies for metabolic disorders.
- To address the limitations of organ availability in liver replacement.
Main Methods:
- Review of current literature on hepatocyte transplantation.
- Analysis of preclinical and clinical studies in metabolic disease models.
- Comparison of outcomes between hepatocyte transplantation and OLT.
Main Results:
- Hepatocyte transplantation has demonstrated efficacy in treating various metabolic disorders.
- This method circumvents the critical shortage of donor organs for OLT.
- It presents a potentially less invasive therapeutic option compared to whole-organ transplantation.
Conclusions:
- Hepatocyte transplantation is a promising alternative for managing metabolic disorders.
- Cellular therapies offer a scalable solution to organ donor limitations.
- Further research is warranted to optimize hepatocyte transplantation protocols.
